The data was good enough for the FDA to review, so it's good enough for me.
If and when new data surfaces, I will analyse that too
I have a degree in Nutrition Science and a Masters of Dietetics. After my research was published into a peer reviewed journal (1 of 2 people to do so in my cohort), I was offered a PhD position to help uncover the mystery of saturated fat and Alzheimer's, but turned it down to continue running my business and making money. I'm probably the only person on this forum that has passed a peer review process by other scientists.
My reasoning is quite simple after some back story. Call me naive, but back when I first started investing, Hotcopper was a tool that I would use to see what the 'smart' people were saying. They owned these stocks, so they know what they are talking about, or so I thought. I bought IMU very early after reading the incredible hype around HER-Vaxx. I soon realised that my interest in research could be of benefit and after I did some digging of my own, I realised how poor the data supporting HER-Vaxx was, so I sold out for a small profit. IMU then went on a great run, and many people were incorrectly evaluating the efficacy of HER-Vaxx, so I shared some of the research that I had done. Despite being unequivocally right, I was defamed publicly for doing so. Soon after, I made predictions about CF33, and now I am following that journey through to completion.
I sacrifice my time so that people (who were like me) can view information in an easy to understand manner to make up their own mind. I may be wrong, but I certainly won't be a parrot or an ostrich with my head in the sand.
https://pubmed.ncbi.nlm.nih.gov/32990613/
